| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | Executive VP, Corporate Strategy
1 company
Bendheim Daniel M serves as a President and CEO at PAHC. Across recent SEC filings that breaks down to 0 buys and 26 sells.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2019 | PAHC Phibro Animal Health Corp | Executive VP, Corporate Strategy | Sale+OE | 9,780 | $31.34 | $306,478.30 | - | |
| Jan 24, 2019 | PAHC Phibro Animal Health Corp | Executive VP, Corporate Strategy | Sale+OE | 7,500 | $31.63 | $237,254.00 | - | |
| Jan 18, 2019 | PAHC Phibro Animal Health Corp | Executive VP, Corporate Strategy | Sale+OE | 7,500 | $32.23 | $241,700.00 | - | |
| Jan 9, 2019 | PAHC Phibro Animal Health Corp | Executive VP, Corporate Strategy | Sale+OE | 5,000 | $32.43 | $162,125.00 | - | |
| Jan 7, 2019 | PAHC Phibro Animal Health Corp | Executive VP, Corporate Strategy | Sale+OE | 7,500 | $31.74 | $238,075.00 | - | |
| Sep 12, 2018 | PAHC Phibro Animal Health Corp | Executive VP, Corporate Strategy | Sale+OE | 2,500 | $44.30 | $110,750.00 | - | |
| Mar 12, 2018 | PAHC Phibro Animal Health Corp | Executive VP, Corporate Strategy | Sale+OE | 23,163 | $40.01 | $926,717.28 | - | |
| Mar 6, 2018 | PAHC Phibro Animal Health Corp | Executive VP, Corporate Strategy | Sale+OE | 3,960 | $40.06 | $158,646.60 | - | |
| Aug 21, 2017 | PAHC Phibro Animal Health Corp | Executive VP, Corporate Strategy | Sale+OE | 4,976 | $40.01 | $199,097.76 | - | |
| Aug 16, 2017 | PAHC Phibro Animal Health Corp | Executive VP, Corporate Strategy | Sale+OE | 7,681 | $40.04 | $307,573.67 | - |